Nanomedicine - Prospective therapeutic and diagnostic applications

Expert Opinion on Biological Therapy

Volumn 5, Issue 1, 2005, Pages 1-5

  Emerich, Dwaine F ^a  

^a LCT BioPharma   (United States)

Author keywords

DNA sequencing; Drug delivery; Nanoparticles; Nanotechnology; Viral detection

Indexed keywords

ANTIGEN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; DNA; DORNASE ALFA; FULLERENE; IMMUNOGLOBULIN; LYSOZYME; NANOPARTICLE; NANOSHELL; NANOTUBE; POLYGLACTIN; POLYMER; RHODAMINE; SILICON DIOXIDE; TETRAMETHYLRHODAMINE; UNCLASSIFIED DRUG; VACCINE;

CHANNEL GATING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DNA SEQUENCE; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; ENCAPSULATION; GENOMICS; MASS MEDIUM; MOLECULAR BIOLOGY; NANOMEDICINE; NANOTECHNOLOGY; PROSPECTIVE STUDY; REVIEW; ROBOTICS; SCREENING TEST; VIRUS DETECTION;

DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOSTRUCTURES;

EID: 12244313429     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.5.1.1     Document Type: Review

References (49)

1. NO AUTHORS LISTED: Nanomedicine: grounds for optimism, and a call for papers. Lancet (2003) 362:673.
2. CLARK H, KOPELMAN R, TJALKENS R et al.: Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors. Anal. Chem. (1999) 71:4837-4843.
3. SUMNER JP, AYLOTT JW, MONSON E, KOPELMAN R: A fluorescent PEBBLE nanosensor for intracellular free zinc. Analyst (2002) 127:11-16.
4. RONDEROS RE, BOSKIS M, CHUNG N et al.: Correlation between myocardial perfusion abnormalities with intermittent imaging using intravenous perfluorocarbon microbubbles and radioisotope imaging during high-dose dipyridamole stress echo. Clin. Cardiol. (2002) 25:103-111.
5. FRENKEL PA, CHEN S, THAI T, SHOHET RV, GRAYBURN PA: DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med. Biol. (2002) 28:817-822.
6. UNGER EC, MATSUNAGA TO, MCCREERY T et al.: Therapeutic applications of microbubbles. Eur. J. Radiol. (2002) 42:160-168.
7. WUNDERBALDINGER P, JOSEPHSON L, WEISSLEDER R: Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticlcs. Bioconjug. Chem. (2002) 13:264-268.
8. LANZA GM, WALLACE KD, SCOTT MJ et al.: A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation (1996) 94:3334-3340.
9. LANZA GM, TROUSIL RL, WALLACE KD et al.: In vitro characterization of a novel, tissue-targeted ultrasonic contrast System with acoustic microscopy. J. Acoust. Soc. Am. (1998) 104:3665-3672.
10. WICKLINE SA, LANZA GM: Nanotechnology for molecular imaging and targeted therapy. Circulation (2003) 107:1092-1095.
11. LANZA GM, LORENZ CH, FISCHER SE et al.: Enhanced detection of thrombi with a novel fibrin targeted magnetic resonance imaging agent. Acad. Radiol. (1998) 5(Suppl. 1):S173-S176.
12. ANDERSON SA, RADER RK, WESTLIN WF et al.: Magnetic resonance contrast enhancement of neovascular with v3-targeted nanoparticlcs. Magn. Reson. Med. (2000) 44:433-439.
13. LANZA GM, ABENDSCHEIN DR, HALL CS et al.: Molecular imaging of stretch induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest. Radiol. (2000) 35:227-234.
14. YU X, SONG S-K, CHEN J et al.: High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn. Reson. Med. (2000) 44:867-872.
15. FLACKE S, FISCHER S, SCOTT MJ et al.: Novel MRI contrast agent for molecular imaging of fibrin Implications for detecting vulnerable plaques. Circulation (2001) 104:1280-1285.
16. LANZA GM, YU X, WINTER PM et al.: Targeted antiproliferative drug delivery to vascular smooth muscle cells with magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation (2002) 106:2842-2847.
17. MCSHANE M: Potential for glucose monitoring with nanoengineered fluorescent biosensors. Diabetes. Technol. Ther. (2002) 4:533-538.
18. CSAKI A, MOLLER R, FRITZSCHE W: Gold nanoparticles as novel label for DNA diagnostics. Expert Rev. Mol. Diagn. (2002) 2:187-193.
19. BARATHUR R, BOOKOUT J, SREEVATSAN S et al.: New disc-based technologies for diagnostic and research applications. Psychiatr. Genet. (2002) 12:193-206.
20. NISHIZAWA M, MENON VP, MARTIN CR: Metal nanotubule membranes with electrochemically switchable ion-transport selectivity. Science (1995) 268:700-702.
21. MELLER A, NIVON L, BRANDIN E et al.: Rapid nanopore discrimination between single polynucleotide molecules. Proc. Natl. Acad. Sci. USA (2000) 97:1079-1084.
22. HOWORKA S, CHELEY S, BAYLEY H: Sequence-specific detection of individual DNA strands using engineered nanopores. Nat. Biotechnol. (2001) 19:636-639.
23. DEAMER DW, AKESON M: Nanopores and nucleic acids: prospects for ultrarapid sequencing. Trends Biotech. (2000) 18:147-151.
24. KUMAR MNV, HELLERMAN G, LOCKEY, RF: Nanoparticle-mediated gene delivery: state of the art. Expert Opin. Biol. Ther. (2004) 4:1213-1224.
25. COHEN S, YOSHIOKA T, LUCARELLI M et al.: Controlled delivery systems for proteins based on poly(lactic/ glycolic acid) microspheres. Pharm. Res. (1992) 8:713-720.
26. MATHIOWITZ E, JACOB J, JONG Y et al.: Biologically erodable microspheres as potential oral drug delivery systems. Nature (1997) 386:410-414. Important advancements in nanosphere technology.
27. BARTUS RT, EMERICH DF, HOTZ J et al.: Vivitrex®, an injectable, extended-release formulation of naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for 1 month in rats. Neuropsychopharmacology (2003) 11:1973-1982.
28. HILLYER J, ALBRECHT R: Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci. (2001) 90:1927-1936.
29. TORCHE A, JOUAN H, CORRE PL et al.: Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment. Int. J. Pharm. (2000) 201:15-27.
30. LUBBEN IVD, KONINGS F, BORCHARD G et al.: In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunhistochemistry. J. Drug Target. (2001) 9:39-47.
31. HUSSAIN N, JAITLEY V, FLORENCE A: Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug Deliv. Rev. (2001) 50:107-142. Detailed review on intestinal translocation.
32. LUTSIAK M, ROBINSON D, COESTER C et al.: Analysis of poly(D,L-lactic-co- glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm. Res. (2002) 19:1480-1487.
33. BUSTAMI R, CHAN H, DEHGHANI F et al.: Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide. Pharm. Res. (2000) 17:1360-1366.
34. LOSCERTALES I, BARRERO A, GUERRERO I et al.: Micro/nano encapsulation via electrified coaxial liquid jets. Science (2002) 295:1695-1698.
35. SANTINI J, CIMA M, LANGER R: A controlled-release microchip. Nature (1999) 397:335-338. Merging drug delivery and computer technology.
36. MARTIN C, KOHLI P: The emerging field of nanotube biotechnology. Nat. Rev. Drug Discov. (2002) 2:29-35.
37. GOLDSTEIN A, AMORY J, MARTIN S et al.: Testosterone delivery using glutamide-based complex high axial ratio microstructures. Bioorg. Med. Chem. (2001) 9:2819-2825.
38. CHEN R, ZHANG Y, WANG D et al.: Noncovalcnt sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J. Am. Chem. Soc. (2001) 123:3838-3839.
39. 60 fullerene. Antimicrob. Agents Chemother. (1993) 37:1707-1710.
40. TSAO N, KANAKAMMA PP, LUH TY et al.: Inhibition of Escherichia coli-induced meningitis by carboxyfullerence. Antimicrob. Agents Chemother. (1999) 43:2275-2277.
41. TSAO N, LUH TY, CHOU CK et al.: Inhibition of group A streptococcus infection by carboxyfullerene. Antimicrob. Agents Chemother. (2001) 45:1788-1793.
42. BOSI S, DA ROS T, CASTELLANO S et al.: Antimycobacterial activity of ionic fullerene derivatives. Bioorg. Med. Chem. Lett. (2000) 10:1043-1045.
43. TABATA Y, MURAKAMI Y, IKADA Y: Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn. J. Cancer Res. (1997) 88:1108-1116.
44. TABATA Y, MURAKAMI Y, IKADA Y: Antitumor effect of poly(ethylene glycol)-modified fullerene. Fullerene Sci. Technol. (1997) 5:989-1007.
45. MIYATA N, YAMAKOSHI T: In: Fullerenes: Recent Advances in the Chemistry and Physics of Fullerenes and Related Materials. Vol. 5. Kadish KM, Ruoff RS (Eds), Electrochemical Society, Pennington, NJ, USA (1997):345-357.
46. DUGAN LL, LOVETT E, CUDDIHY S et al.: Carboxyfullerenes as neuroprotective antioxidants. In: Fullerenes: Chemistry, Physics, and Technology. Kadish KM, Ruoff RS (Eds), John Wiley and Sons, New York, USA (2000):467-480.
47. HIRSCH LR, JACKSON JB, LEE A et al.: A whole blood immunoassay using gold nanoshells. Anal. Chem. (2003) 75:2377-2381.
48. PATOLSKY F, ZHENG G, HAYDEN O et al.: Electrical detection of single viruses. Proc. Natl. Acad. Sci. USA (2004) 101(39):14017-14022.
49. EMERICH DF, THANOS CG: Nanotechnology and medicine. Expert Opin. Biol. Ther. (2003) 3:1-9.